Accurate Estimation of Some Pharmaceutical Compounds Using HPLC Technology

Qasim Mezban Salih *

Wasit University, College of Science, Iraq.

*Author to whom correspondence should be addressed.


Abstract

For the assessment of different chemical components in pharmaceutical and biological samples, High Performance Liquid Chromatography (HPLC) can be defined as a commonly utilized analytical method in pharmaceutical samples. HPLC offers high sensitivity, specificity, and accuracy, making it a preferred method for the analysis of complex samples. In this technique, the sample is prepared by extracting, purifying, and concentrating the target analyte from the matrix. Mobile and stationary phases are after that used in chromatographic separation of the prepared sample. Several detectors, including fluorescence, UV-vis, and mass spectrometry, are used to identify and measure the eluted compounds. HPLC is capable of estimating a wide range of elements, including small molecules, peptides, and proteins, making it an essential tool in pharmaceutical research and development. The theoretical plates, peak tailing, and % assay have not been significantly impacted by the deliberate alterations made to the method. This implies that the existing technique is robust. The low values of LOQ and LOD show how sensitive the suggested approach is. The current research used a standard drug solution with six replicates to examine the system suitability parameters. It was discovered that the computed parameters fell under the acceptable criteria. The theoretical plate count, tailing factor, and HETP parameters are all within acceptable ranges. The results of this work are compared with those of earlier research. Upon analyzing the chart, it can be inferred that the proposed method presents certain benefits. The investigation employed a Kromasil C18 column. The obtained retention time is comparatively lower than that of all other methodologies. The maximum quantifiable threshold is 600 μg/mL, surpassing or equating all of the aforementioned techniques. The duration of the execution is also minimal. Therefore, the author draws the conclusion that the HPLC method proposed exhibits sensitivity and reproducibility in analysis of etodolac and thiocolchicoside in combined tablet dosage form, while also requiring a short analysis time.

Keywords: HPLC, drugs, accuracy, etodolac, thiocolchicoside


How to Cite

Salih, Qasim Mezban. 2023. “Accurate Estimation of Some Pharmaceutical Compounds Using HPLC Technology”. Asian Journal of Applied Chemistry Research 14 (4):1-16. https://doi.org/10.9734/ajacr/2023/v14i4272.

Downloads

Download data is not yet available.

References

Balfour JA, Buckley MM-T. Etodolac: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs. 1991;42:274-299.

Humber LG. Etodolac: The chemistry, pharmacology, metabolic disposition, and clinical profile of a novel anti‐inflammatory pyranocarboxylic acid. Med Res Rev. 1987;7(1):1-28.

Pharmacopoeia I. Government of India ministry of health and family welfare Ghaziabad. Publ by Indian Pharmacopoeia Comm. 2010;1:49-83.

Pharmacopoeia B. The Stationary Office Medicinal and Pharmaceutical Substances (A–I). London. 2009;III: 2567.

Test TF. The United States Pharmacopoeia 32 National Formulary 27, United States Pharmacopoeia convention. Inc, Rockville, MD. 2009;725.

Mascia MP, Bachis E, Obili N, et al. Thiocolchicoside inhibits the activity of various subtypes of recombinant GABAA receptors expressed in Xenopus laevis oocytes. Eur J Pharmacol. 2007;558(1-3):37-42.

Tüzün F, Ünalan H, Öner N, et al. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Jt Bone Spine. 2003;70(5):356-361.

Soonawalla DF, Joshi N. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm. J Indian Med Assoc. 2008;106(5): 331-335.

Kamath A. Thiocolchicoside: A review. DHR Int J Med Sci. 2013;4(2):39-45.

Rathod K, Patel J. Simultaneous estimation of etodolac and thiocolchicoside in their combined marketed formulation by RP-HPLC. Int J PharmTech Res. 2012; 4(4):1513-1519.

Pandey R, Patil P, Bari S. Validated RPHPLC method for simultaneous estimation of thiocolchicoside & etodolac in bulk drug and in pharmaceutical dosage form. Asian J Biochem Pharm Res. 2011; 2:105-109.

Alagar R, Priyadarshini C, David B, Rao K, Selvakumar D. Validated RP-HPLC method for simultaneous estimation of etodolac & thiocolchicoside in pharmaceutical tablet dosage form. J Pharm Res. 2012;5(8):4577-4579.

Pradnya PP, Ghodeswar BC, Chaudhari Sr. Simultaneous Estimation of Etodolac & Thiocolchicoside in Bulk & Tablet dosage form by using rphplc method. inven rapid pharm anal qual assur. Published online 2012.

Patel A, Shah B. RP-HPLC method development and validation using factorial design for simultaneous estimation of thiocolchicoside and etodolac with forced degradation studies. J Pharm Sci Bio Res. 2014; 4(6):374-382.

Tekade SW, Havele SS, Dhaneshwar SR. Validated HPTLC method for simultaneous estimation of etodolac and thiocolchicoside in bulk drug and formulation. J Pharm Biomed Sci. 2012;23(07):1-4.

Guideline ICHHT. Validation of analytical procedures: text and methodology. Q2. 2005;1(20):5.